Combined 8q gain and 10q loss predicts for relapse following radical radiotherapy in intermediate risk prostate cancer

被引：0
|
作者：
Zafarana, Gaetano
Ishkanian, Adrian
Maloff, Chad
Thoms, John
Squire, Jeremy
Pintile, Melania
Milosevic, Michael
Lam, Wan
van der Kvast, Theo
Bristow, Robert G.
机构：
来源：
CANCER RESEARCH | 2010年 / 70卷
关键词：
D O I：
10.1158/1538-7445.AM10-2136
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2136
引用
收藏
页数：4
相关论文
共 30 条
  • [21] Risk Factors Predicting Relapse 10 Years Following Extreme Dose-Escalated SBRT for Intermediate-Risk Prostate Cancer: Is De-Intensification Feasible in Unfavorable Subgroups?
    Meier, R.
    Kaplan, I. D.
    Bloch, D.
    Cotrutz, C.
    Chen, R. C.
    Kane, B. L.
    Henning, G.
    Woodhouse, S. A., Jr.
    Crabtree, T.
    Fuller, D. B.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2023, 117 (02): : E416 - E417
  • [22] Number of Unfavorable Intermediate-Risk Factors Predicts Pathologic Upstaging and Prostate Cancer-Specific Mortality Following Radical Prostatectomy: Results From the SEARCH Database
    Zumsteg, Zachary S.
    Chen, Zinan
    Howard, Lauren E.
    Amling, Christopher L.
    Aronson, William J.
    Cooperberg, Matthew R.
    Kane, Christopher J.
    Terris, Martha K.
    Spratt, Daniel E.
    Sandler, Howard M.
    Freedland, Stephen J.
    PROSTATE, 2017, 77 (02): : 154 - 163
  • [23] IN MEN WITH RISING PSA AFTER RADICAL PROSTATECTOMY, 8Q24 PROSTATE CANCER RISK ALLELES HELP PREDICT THREATENING CANCER PROGRESSION AND NEED FOR SALVAGE THERAPY
    Catalona, William J.
    Jin, Carol H.
    Roehl, Kimberly A.
    Loeb, Stacy
    Helfand, Brian T.
    Suarez, Brian K.
    JOURNAL OF UROLOGY, 2009, 181 (04): : 269 - 269
  • [24] A west African ancestry-associated SNP on 8q24 predicts a positive biopsy in African American men with suspected prostate cancer following PSA screening
    Gu, Jian
    Chery, Lisly
    Gonzalez, Graciela M. Nogueras
    Huff, Chad
    Strom, Sara
    Jones, Jeffrey A.
    Griffith, Donald P.
    Canfield, Steven E.
    Wang, Xuemei
    Huang, Xuelin
    Roberson, Pamela
    Meng, Qing H.
    Troncoso, Patricia
    Ittmann, Michael
    Covinsky, Michael
    Scheurer, Michael
    Irizarry Ramirez, Margarita
    Pettaway, Curtis A.
    PROSTATE, 2024, 84 (07): : 694 - 705
  • [25] A comparison of biochemical relapse-free survival and initiation of salvage therapy in patients with intermediate-risk prostate cancer treated with radical prostatectomy, external beam radiotherapy, or permanent seed implantation
    Vassil, A. D.
    Murphy, E. S.
    Reddy, C. A.
    Altman, A.
    Chehade, N.
    Ulchaker, J.
    Klein, E. A.
    Ciezki, J. P.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2007, 69 (03): : S327 - S328
  • [26] A comparison of biochemical relapse-free survival and initiation of salvage therapy in patients with intermediate-risk prostate cancer treated with open radical prostatectomy, laparoscopic radical prostatectomy, external beam radiotherapy, or permanent seed implantation
    Vassil, A. D.
    Murphy, E. S.
    Reddy, C. A.
    Altman, A.
    Chehade, N.
    Ulchaker, J.
    Angermeier, K. W.
    Klein, E. A.
    Ciezki, J. P.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008, 72 (01): : S286 - S286
  • [27] Chromosome 8q23.3, 10p14 and 11q23.1 variants modify colorectal cancer risk in Lynch syndrome – a combined analysis of the Australian, Dutch and Polish Lynch syndrome cohorts
    Bente A Talseth-Palmer
    Juul T Wijnen
    Ingvild S Brenne
    Shantie Jagmohan-Changur
    Katie A Ashton
    Carli M Tops
    Tiffany-Jane Evans
    Mary McPhillips
    Claire Groombridge
    Janina Suchy
    Grzegorz Kurzawski
    Allan Spigelman
    Pål Møller
    Hans M Morreau
    Tom Van Wezel
    Jan Lubinski
    Hans FA Vasen
    Rodney J Scott
    Hereditary Cancer in Clinical Practice, 10 (Suppl 2)
  • [28] After ASCENDE-RT: Biochemical and survival outcomes following combined external beam radiotherapy and low-dose-rate brachytherapy for high-risk and unfavourable intermediate-risk prostate cancer, a population-based analysis
    Oh, Justin
    Morris, W. James
    Spadinger, Ingrid
    Tyldesley, Scott
    Keyes, Mira
    Halperin, Ross
    Crook, Juanita
    Lapointe, Vincent
    Pickles, Tom
    BRACHYTHERAPY, 2022, 21 (05) : 605 - 616
  • [29] Prostate cancer (ca) c-myc (8q24) amplification detected by fluorescence in situ hybridization (FISH) and MIB-I proliferation in needle biopsy (NBx) predict risk of clinical progression after radical prostatectomy (RP)
    Sebo, TJ
    Dora, CD
    Lan, F
    Kondo, Y
    Slezak, JM
    Bergstralh, EJ
    Jenkins, RB
    MODERN PATHOLOGY, 2005, 18 : 163A - 163A
  • [30] Prostate cancer (Ca) c-myc (8q24) amplification detected by fluorescence in situ hybridization (FISH) and MIB-I proliferation in needle biopsy (NBx) predict risk of clinical progression after radical prostatectomy (RP)
    Sebo, TJ
    Dora, CD
    Lan, F
    Kondo, Y
    Slezak, JM
    Bergstralh, EJ
    Jenkins, RB
    LABORATORY INVESTIGATION, 2005, 85 : 163A - 163A
123